Perkins Seminar: Professor Des Richardson

Event Date and Time:
Thursday 18th April, 2019 @ 12:00pm - 1:00pm

Venue:
McCusker Auditorium, Harry Perkins Institute of Medical Research, Nedlands

Professor Des Richardson holds the Chair of Cancer Cell Biology at the University of Sydney, Australia, and is a National Health and Medical Research Council (NHMRC) of Australia Senior Principal Research Fellow.

He has published 415 articles, reviews, patents, chapters etc., over his career with >93% as first, senior or corresponding author (H-index: 85; >30,000 citations over his entire career; with >15,900 citations over the past 5 years and H-index: 57 over the past 5 years).

He is Executive Editor of BBA-General Subjects and has served on the Editorial Boards of 43 international journals, including J. Biol. Chem., Antioxidants Redox Signaling, Biochem. J., BBA-Mol Cell Res, Mol. Pharmacol., Pharmacol. Res., etc.

As a major translational research achievement, he has developed the anti-cancer and anti-metastatic drug, DpC, which overcomes P-glycoprotein-mediated drug resistance and up-regulates the potent metastasis suppressor, NDRG1.

This has led to commercialisation of DpC and the development of the international company, Oncochel Therapeutics LLC, USA and its Australian subsidiary, Oncochel Therapeutics Pty Ltd. Notably, DpC has entered multi-centre Phase I clinical trials for the treatment of advanced and resistant cancer.

Events Calendar

S
M
T
W
T
F
S
1
2
4
5
6
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Back To Top